4,646 research outputs found
A Difference Version of Nori's Theorem
We consider (Frobenius) difference equations over (F_q(s,t), phi) where phi
fixes t and acts on F_q(s) as the Frobenius endomorphism. We prove that every
semisimple, simply-connected linear algebraic group G defined over F_q can be
realized as a difference Galois group over F_{q^i}(s,t) for some i in N. The
proof uses upper and lower bounds on the Galois group scheme of a Frobenius
difference equation that are developed in this paper. The result can be seen as
a difference analogue of Nori's Theorem which states that G(F_q) occurs as
(finite) Galois group over F_q(s).Comment: 29 page
The origin of defects induced in ultra-pure germanium by Electron Beam Deposition
The creation of point defects in the crystal lattices of various
semiconductors by subthreshold events has been reported on by a number of
groups. These observations have been made in great detail using sensitive
electrical techniques but there is still much that needs to be clarified.
Experiments using Ge and Si were performed that demonstrate that energetic
particles, the products of collisions in the electron beam, were responsible
for the majority of electron-beam deposition (EBD) induced defects in a
two-step energy transfer process. Lowering the number of collisions of these
energetic particles with the semiconductor during metal deposition was
accomplished using a combination of static shields and superior vacuum
resulting in devices with defect concentrations lower than cm, the measurement limit of our deep level transient
spectroscopy (DLTS) system. High energy electrons and photons that samples are
typically exposed to were not influenced by the shields as most of these
particles originate at the metal target thus eliminating these particles as
possible damage causing agents. It remains unclear how packets of energy that
can sometimes be as small of 2eV travel up to a m into the material while
still retaining enough energy, that is, in the order of 1eV, to cause changes
in the crystal. The manipulation of this defect causing phenomenon may hold the
key to developing defect free material for future applications.Comment: 18 pages, 9 figure
Safety in home care: A research protocol for studying medication management
<p>Abstract</p> <p>Background</p> <p>Patient safety is an ongoing global priority, with medication safety considered a prevalent, high-risk area of concern. Yet, we have little understanding of the supports and barriers to safe medication management in the Canadian home care environment. There is a clear need to engage the providers and recipients of care in studying and improving medication safety with collaborative approaches to exploring the nature and safety of medication management in home care.</p> <p>Methods</p> <p>A socio-ecological perspective on health and health systems drives our iterative qualitative study on medication safety with elderly home care clients, family members and other informal caregivers, and home care providers. As we purposively sample across four Canadian provinces: Alberta (AB), Ontario (ON), Quebec (QC) and Nova Scotia (NS), we will collect textual and visual data through home-based interviews, participant-led photo walkabouts of the home, and photo elicitation sessions at clients' kitchen tables. Using successive rounds of interpretive description and human factors engineering analyses, we will generate robust descriptions of managing medication at home within each provincial sample and across the four-province group. We will validate our initial interpretations through photo elicitation focus groups with home care providers in each province to develop a refined description of the phenomenon that can inform future decision-making, quality improvement efforts, and research.</p> <p>Discussion</p> <p>The application of interpretive and human factors lenses to the visual and textual data is expected to yield findings that advance our understanding of the issues, challenges, and risk-mitigating strategies related to medication safety in home care. The images are powerful knowledge translation tools for sharing what we learn with participants, decision makers, other healthcare audiences, and the public. In addition, participants engage in knowledge exchange throughout the study with the use of participatory data collection methods.</p
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
The gold standard for a definitive diagnosis of Parkinson disease (PD) is the pathologic finding of aggregated α-synuclein into Lewy bodies and for Alzheimer disease (AD) aggregated amyloid into plaques and hyperphosphorylated tau into tangles. Implicit in this clinicopathologic-based nosology is the assumption that pathologic protein aggregation at autopsy reflects pathogenesis at disease onset. While these aggregates may in exceptional cases be on a causal pathway in humans (e.g., aggregated α-synuclein in SNCA gene multiplication or aggregated β-amyloid in APP mutations), their near universality at postmortem in sporadic PD and AD suggests they may alternatively represent common outcomes from upstream mechanisms or compensatory responses to cellular stress in order to delay cell death. These 3 conceptual frameworks of protein aggregation (pathogenic, epiphenomenon, protective) are difficult to resolve because of the inability to probe brain tissue in real time. Whereas animal models, in which neither PD nor AD occur in natural states, consistently support a pathogenic role of protein aggregation, indirect evidence from human studies does not. We hypothesize that (1) current biomarkers of protein aggregates may be relevant to common pathology but not to subgroup pathogenesis and (2) disease-modifying treatments targeting oligomers or fibrils might be futile or deleterious because these proteins are epiphenomena or protective in the human brain under molecular stress. Future precision medicine efforts for molecular targeting of neurodegenerative diseases may require analyses not anchored on current clinicopathologic criteria but instead on biological signals generated from large deeply phenotyped aging populations or from smaller but well-defined genetic-molecular cohorts
Belowground DNA-based techniques: untangling the network of plant root interactions
Contains fulltext :
91591.pdf (publisher's version ) (Closed access)7 p
Outcome measurement in functional neurological disorder: a systematic review and recommendations.
OBJECTIVES: We aimed to identify existing outcome measures for functional neurological disorder (FND), to inform the development of recommendations and to guide future research on FND outcomes. METHODS: A systematic review was conducted to identify existing FND-specific outcome measures and the most common measurement domains and measures in previous treatment studies. Searches of Embase, MEDLINE and PsycINFO were conducted between January 1965 and June 2019. The findings were discussed during two international meetings of the FND-Core Outcome Measures group. RESULTS: Five FND-specific measures were identified-three clinician-rated and two patient-rated-but their measurement properties have not been rigorously evaluated. No single measure was identified for use across the range of FND symptoms in adults. Across randomised controlled trials (k=40) and observational treatment studies (k=40), outcome measures most often assessed core FND symptom change. Other domains measured commonly were additional physical and psychological symptoms, life impact (ie, quality of life, disability and general functioning) and health economics/cost-utility (eg, healthcare resource use and quality-adjusted life years). CONCLUSIONS: There are few well-validated FND-specific outcome measures. Thus, at present, we recommend that existing outcome measures, known to be reliable, valid and responsive in FND or closely related populations, are used to capture key outcome domains. Increased consistency in outcome measurement will facilitate comparison of treatment effects across FND symptom types and treatment modalities. Future work needs to more rigorously validate outcome measures used in this population
High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients
Osteosarcoma of the foot is a very rare presentation of a rare tumor entity. In a retrospective analysis, we investigated tumor- and treatment-related variables and outcome of patients registered in the Cooperative Osteosarcoma Study Group (COSS) database between January 1980 and April 2016 who suffered from primary high-grade osteosarcoma of the foot. Among the 23 eligible patients, median age was 32 years (range: 6-58 years), 10 were female, and 13 were male. The tarsus was the most commonly affected site (n=16). Three patients had primary metastases. All patients were operated: 5 underwent primary surgery and 18 received surgery following preoperative chemotherapy. In 21 of the 23 patients, complete surgical remission was achieved. In 4 of 17 patients, a poor response to neoadjuvant chemotherapy was observed in the resected primary tumors. Median follow-up was 4.2 years (range: 0.4-18.5). At the last follow-up, 15 of the 23 patients were alive and 8 had died. Five-year overall and event-free survival estimates were 64% (standard error (SE) 12%) and 54% (SE 13%), which is similar to that observed for osteosarcoma in general. Event-free and overall survival correlated with primary metastatic status and completeness of surgery. Our findings show that high-grade osteosarcoma in the foot has a similar outcome as osteosarcoma of other sites
Delocalized single-photon Dicke states and the Leggett- Garg inequality in solid state systems
We show how to realize a single-photon Dicke state in a large one-dimensional
array of two- level systems, and discuss how to test its quantum properties.
Realization of single-photon Dicke states relies on the cooperative nature of
the interaction between a field reservoir and an array of two-level-emitters.
The resulting dynamics of the delocalized state can display Rabi-like
oscillations when the number of two-level emitters exceeds several hundred. In
this case the large array of emitters is essentially behaving like a
mirror-less cavity. We outline how this might be realized using a
multiple-quantum-well structure and discuss how the quantum nature of these
oscillations could be tested with the Leggett-Garg inequality and its
extensions.Comment: 29 pages, 5 figures, journal pape
- …